Publications and Media
Filter By
Resource Type
Therapeutic Area
September 17, 2024 | Press Release
Sysmex Inostics’ RAS-RAF-SEQ Assay Receives New York State Department of Health CLEP Approval for Use in Clinical Trials
RAS RAF
August 27, 2024 | Press Release
Clearance of Circulating Tumor HPV-DNA, Monitored Using HPV-SEQ, Predicts Improved Survival: A JAMA Oncology Publication
August 6, 2024 | Press Release
Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing
June 6, 2024 | Publication|JAMA
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer
HPV
OPC
February 7, 2024 | Webinar
cfHPV-DNA: A new prognostic biomarker in HPV driven OPSCC
HPV
OPSCC
October 24, 2023 | Publication|Ann Oncol
870P Dynamic cfHPV DNA changes during induction chemotherapy as an early indicator of treatment responsiveness for locally advanced head and neck cancer patients
HNC
HPV
October 24, 2023 | Publication|Ann Oncol
886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment
HPV
OPC
August 30, 2023 | Blog
MRD in AML: the next step in fighting leukemia
AML-MRD
leukemia
April 17, 2023 | Press Release
Sysmex Inostics Exhibits at American Association for Cancer Research Annual Meeting 2023 in Orlando
April 13, 2023 | Press Release
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development